111 Inc
NASDAQ:YI
111 Inc
Inventory
111 Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
111 Inc
NASDAQ:YI
|
Inventory
¥1.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Inventory
¥4.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Inventory
¥3.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Inventory
¥4.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
27%
|
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Inventory
¥3.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
Inventory
¥863.8m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
111 Inc
Glance View
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The firm mainly conducts its business in the domestic market.
See Also
What is 111 Inc's Inventory?
Inventory
1.3B
CNY
Based on the financial report for Sep 30, 2025, 111 Inc's Inventory amounts to 1.3B CNY.
What is 111 Inc's Inventory growth rate?
Inventory CAGR 5Y
6%
Over the last year, the Inventory growth was -18%.